AU2003284772A1 - PHARMACEUTICAL COMPOSITION FOR CONTROLING THE STABILITY OF HIF-1Alpha - Google Patents

PHARMACEUTICAL COMPOSITION FOR CONTROLING THE STABILITY OF HIF-1Alpha

Info

Publication number
AU2003284772A1
AU2003284772A1 AU2003284772A AU2003284772A AU2003284772A1 AU 2003284772 A1 AU2003284772 A1 AU 2003284772A1 AU 2003284772 A AU2003284772 A AU 2003284772A AU 2003284772 A AU2003284772 A AU 2003284772A AU 2003284772 A1 AU2003284772 A1 AU 2003284772A1
Authority
AU
Australia
Prior art keywords
1alpha
hif
controling
stability
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003284772A
Inventor
Joo-Won Jeong
Kyu-Won Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003284772A1 publication Critical patent/AU2003284772A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91051—Acyltransferases other than aminoacyltransferases (general) (2.3.1)
    • G01N2333/91057—Acyltransferases other than aminoacyltransferases (general) (2.3.1) with definite EC number (2.3.1.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003284772A 2002-11-26 2003-11-26 PHARMACEUTICAL COMPOSITION FOR CONTROLING THE STABILITY OF HIF-1Alpha Abandoned AU2003284772A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20020074137 2002-11-26
KR20020074138 2002-11-26
KR10-2002-0074138 2002-11-26
KR10-2002-0074137 2002-11-26
PCT/KR2003/002577 WO2004047852A1 (en) 2002-11-26 2003-11-26 PHARMACEUTICAL COMPOSITION FOR CONTROLING THE STABILITY OF HIF-1α

Publications (1)

Publication Number Publication Date
AU2003284772A1 true AU2003284772A1 (en) 2004-06-18

Family

ID=32396378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003284772A Abandoned AU2003284772A1 (en) 2002-11-26 2003-11-26 PHARMACEUTICAL COMPOSITION FOR CONTROLING THE STABILITY OF HIF-1Alpha

Country Status (2)

Country Link
AU (1) AU2003284772A1 (en)
WO (1) WO2004047852A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101514230B (en) * 2008-02-18 2011-08-10 北京市肿瘤防治研究所 Monoclone antibody of ARD1 and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795724A (en) * 1997-09-12 1998-08-18 Incyte Pharmaceuticals, Inc. Human N-acetyl transferase

Also Published As

Publication number Publication date
WO2004047852A1 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
AU2003291103A1 (en) Pharmaceutical composition
HK1083835A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
IL164455A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
IL174128A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
AU2003296897A1 (en) Pharmaceutical formulations of camptothecine derivatives
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL173602A0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627A0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
IL173051A0 (en) N-glucoside derivatives and pharmaceutical compositions containing the same
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
IL172937A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
IL175214A0 (en) 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
AU2003285526A1 (en) Use of polyethylene compositions
HK1086485A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
IL174249A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL177496A0 (en) Amido-substituted hydroxy -6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
AU2003250372A1 (en) Pharmaceutical composition
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2003292263A1 (en) Use of substituted 2-phenylbenzimidazoles as medicaments
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase